| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Mazumdar Claire is a Chief Executive Officer at Bicara Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $8.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE | 15,000 | $23.61 | $354,145.50 | -4.0% | - | - | |
| Mar 20, 2026 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE | 15,000 | $18.82 | $282,365.69 | -1.5% | - | - | |
| Mar 9, 2026 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE | 36,766 | $19.17 | $704,657.16 | -9.8% | - | - | |
| Nov 24, 2025 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE | 41,163 | $18.86 | $776,428.85 | -11.7% | -13.1% | - | |
| Oct 16, 2025 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE | 24,103 | $18.83 | $453,760.67 | -7.2% | -3.5% | - | |
| Oct 15, 2025 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE | 24,734 | $18.88 | $466,936.46 | -3.8% | -6.8% | - |